Prevalence and factors associated with depression and suicidal ideation among French students in 2016: A national study.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
08 2023
Historique:
received: 13 02 2023
revised: 21 05 2023
accepted: 22 05 2023
medline: 23 10 2023
pubmed: 10 6 2023
entrez: 9 6 2023
Statut: ppublish

Résumé

Depression is one of the leading causes of morbidity worldwide and increases the risk of suicide. Students are known as a population at risk for depression. This study aimed to evaluate the prevalence of 12 months major depressive episode (MDE) and suicidal thoughts in French students and investigate associated factors. A questionnaire was sent by email to a representative sample of the French student population between April 28th and June 27th 2016. MDE was assessed using the Composite International Diagnostic Interview Short Form (CIDI-SF). The response rate was 18.7% (N= 18,875). Prevalence of 12 months MDE was 15.8%, and suicidal thoughts was 9%. Factors associated with MDE were being a woman, study field (law/eco, human/social sciences, and medical), having failed midterms exams or dropout, refusal or stop social scholarship, and subjective financial difficulties. Factors associated with suicidal thoughts were study field (human/social sciences), having failed midterms exams or dropout, and important subjective financial difficulties. The use of CIDI-SF allows comparison with the 2017 French national study, and showed more MDE in students than in the general population. This is the only national study on French students before COVID 19 pandemic.

Identifiants

pubmed: 37295352
pii: S0165-1781(23)00213-5
doi: 10.1016/j.psychres.2023.115263
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115263

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Y.M. received funding from the University of Paris Nanterre, Inserm, GHU Sainte-Anne, Fondation de France, Fondation Pierre Deniker. Yannick Morvan is or has been a member of various professional and scientific organisations of or involving psychologists (AEPU, AFTCC, AFRC, APA, APS, IdPsy, IEPA, FFPP, SFP). He is also a member of the scientific college of the Observatoire National de la Vie Etudiante (OVE) and of the scientific committee of the Encéphale congress. He carried out a consultancy mission for Ernst & Young in 2007. B.C. has received speaking fees from Janssen Cilag, Lundbeck and Eisai, outside the submitted work. A.C., and A.F. declare no competing interests.

Auteurs

Ariel Frajerman (A)

Institute of Psychiatry and Neurosciences de Paris, INSERM UMR 1266, Pathophysiology of Psychiatric Diseases, University of Paris, 75014 Paris, France; Institute of Psychiatry GDR 3557 of Psychiatry, 75014 Paris, France; MOODS Team, INSERM U1178, CESP, Université Paris-Saclay, Faculté de Médecine Paris- Saclay, Le Kremlin Bicêtre, F-94275, France; Service Hospitalo-Universitaire de Psychiatrie de Bicêtre, Mood Center Paris Saclay, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital de Bicêtre, F-94275, France. Electronic address: ariel.frajerman@inserm.fr.

Astrid Chevance (A)

Center for Research and Epidemiology and Statistics, Université de Paris, Inserm UMR 1153 Hôtel Dieu, Paris; Service d'épidémiologie clinique, Hôpitaux Paris Centre, APHP, Paris.

Boris Chaumette (B)

Institute of Psychiatry and Neurosciences de Paris, INSERM UMR 1266, Pathophysiology of Psychiatric Diseases, University of Paris, 75014 Paris, France; Institute of Psychiatry GDR 3557 of Psychiatry, 75014 Paris, France; PEPIT, GHU Paris Psychiatrie et Neurosciences, 75014 Paris, France; Department of Psychiatry, McGill University, Montreal, Canada.

Yannick Morvan (Y)

Université Paris Nanterre, UFR SPSE, laboratoire CLIPSYD, UR4430; Inserm U1018, CESP, Equipe Psychiatrie du développement et trajectoires.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH